November 3, 2021
Related News
Other posts that you should not miss.
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the …
June 3, 2019
ProAxsis Limited (www.proaxsis.com) today announces that it has successfully registered a CE Mark for its ProteaseTag® Active Plasmin …
January 8, 2018
ProAxsis Ltd today announces that the company has completed the development process for NEATstik®, a novel point-of-care …
September 4, 2017